Evaluation and comparison of two commercially available targeted next-generation sequencing platforms to assist oncology decision making.

Weiss, Glen J; Hoff, Brandi R; Whitehead, Robert P; Sangal, Ashish; Gingrich, Susan A; Penny, Robert J; Mallery, David W; Morris, Scott M; Thompson, Eric J; Loesch, David M; Khemka, Vivek

Weiss, Glen J; Hoff, Brandi R; Whitehead, Robert P; Sangal, Ashish; Gingrich, Susan A; Penny, Robert J; Mallery, David W; Morris, Scott M; Thompson, Eric J; Loesch, David M; Khemka, Vivek.

Afiliação

Weiss GJ; Cancer Treatment Centers of America, Western Regional Medical Center, Goodyear, AZ, USA.
Hoff BR; Cancer Treatment Centers of America, Western Regional Medical Center, Goodyear, AZ, USA.
Whitehead RP; Cancer Treatment Centers of America, Western Regional Medical Center, Goodyear, AZ, USA.
Sangal A; Cancer Treatment Centers of America, Western Regional Medical Center, Goodyear, AZ, USA.
Gingrich SA; Cancer Treatment Centers of America, Western Regional Medical Center, Goodyear, AZ, USA.
Penny RJ; Paradigm Diagnostics, Phoenix, AZ, USA.
Mallery DW; Paradigm Diagnostics, Phoenix, AZ, USA.
Morris SM; Paradigm Diagnostics, Phoenix, AZ, USA.
Thompson EJ; Paradigm Diagnostics, Phoenix, AZ, USA.
Loesch DM; Paradigm Diagnostics, Phoenix, AZ, USA.
Khemka V; Cancer Treatment Centers of America, Western Regional Medical Center, Goodyear, AZ, USA.